Jeffrey Hagedorn, MD
Neurology · Columbus, INNPI 1679529879
Payments from drug & device makers
Across 251 payments — averaging $11.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$631
- Supernus Pharmaceuticals, Inc.$328
- EMD Serono, Inc.$208
- Eisai Inc.$178
- Novartis$175
- Sanofi$170
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,893100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 65 | $631 |
| Supernus Pharmaceuticals, Inc. | 32 | $328 |
| EMD Serono, Inc. | 24 | $208 |
| Eisai Inc. | 10 | $178 |
| Novartis | 15 | $175 |
| Sanofi | 11 | $170 |
| Biogen | 9 | $141 |
| Teva Pharmaceuticals USA, Inc. | 12 | $115 |
| Genentech USA, Inc. | 9 | $110 |
| Sunovion Pharmaceuticals Inc. | 17 | $109 |
| Acadia Pharmaceuticals Inc | 6 | $92 |
| AbbVie | 4 | $78 |
| Greenwich Biosciences, Inc. | 3 | $61 |
| Jazz Pharmaceuticals Inc. | 4 | $53 |
| Lilly USA, LLC | 4 | $49 |
| AstraZeneca | 3 | $48 |
| Avanir Pharmaceuticals, Inc. | 3 | $44 |
| Neurocrine Biosciences, Inc. | 3 | $40 |
| Adamas Pharmaceuticals, Inc. | 2 | $26 |
| Banner Life Sciences, LLC | 2 | $25 |
| Johnson & Johnson | 2 | $25 |
| Upsher-smith Laboratories LLC | 1 | $25 |
| Pfizer | 2 | $24 |
| Harmony Biosciences LLC | 1 | $21 |
| Amgen | 1 | $20 |
| GE HealthCare | 1 | $19 |
| MDD US Operations, LLC | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Aprecia Pharmaceuticals, LLC | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| SK Life Science, Inc. | 1 | $15 |
How this compares
$2,893 in reported general payments places this provider in the 50th percentile of 308 neurology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ropinirole Hcl | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other neurology in Columbus
- Kristi GeorgeIndianapolis$10.8M
- Craig HerrmanIndianapolis$7.8M
- Martin FarlowIndianapolis$4.8M
- Jared BroschIndianapolis$4.7M
- Ajay GuptaFort Wayne$2.5M
- Christopher WilsonAvon$2M
- Alexandru BarboiIndianapolis$1.9M
- William ConteMerrillville$1.7M
- James StevensFort Wayne$1.5M
- Kathryn NevelIndianapolis$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.